Literature DB >> 10197138

Selective lateral neck dissection for laryngeal cancer with limited metastatic disease: is it indicated?

A Ferlito1, A Rinaldo.   

Abstract

The most important prognostic factor in cancer of the larynx is the presence of cervical metastatic disease, which is the most common type of recurrence in such patients. Because micrometastases cannot be detected pre-operatively at present, selective lateral neck dissection is increasingly recommended as the standard treatment for patients with a clinically negative neck in order to reduce the recurrence rate. In cases of N+ disease, selective lateral neck dissection can be as valid as modified radical neck dissection, providing patients have only limited, occult metastatic disease.

Entities:  

Mesh:

Year:  1998        PMID: 10197138     DOI: 10.1017/s0022215100142392

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  4 in total

1.  The Relationship between the Localization, Size, Stage and Histopathology of the Primary Laryngeal Tumor with Neck Metastasis.

Authors:  Vahit Mutlu; Harun Ucuncu; Enver Altas; Bulent Aktan
Journal:  Eurasian J Med       Date:  2014-02

2.  Significance of level v lymph node dissection in clinically node positive oral cavity squamous cell carcinoma and evaluation of potential risk factors for level v lymph node metastasis.

Authors:  Devendra G Parikh; Yogen P Chheda; Shakuntala V Shah; Ashok M Patel; Mohit R Sharma
Journal:  Indian J Surg Oncol       Date:  2013-04-12

3.  Nodal metastases from laryngeal carcinoma and their correlation with certain characteristics of the primary tumor.

Authors:  Kamaljit Kaur; Nishi Sonkhya; A S Bapna
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2002-10

Review 4.  Incidental metastases of well-differentiated thyroid carcinoma in lymph nodes of patients with squamous cell head and neck cancer: eight cases with a review of the literature.

Authors:  Leonardo Resta; Domenico Piscitelli; Maria Grazia Fiore; Vincenzo Di Nicola; Maria Luisa Fiorella; Anna Maria Fiorella; Anna Altavilla; Andrea Marzullo
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-10       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.